文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

抗坏血酸、糖皮质激素和硫胺素对脓毒症健康相关生活质量的影响

Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Health-Related Quality of Life in Sepsis.
PubMed 文献 · Crit Care Explor · 2020-11-23
一句话结论在脓毒症休克患者中,与安慰剂相比,抗坏血酸、氢化可的松和硫胺素联合治疗未改善90天健康相关生活质量。

结果显示干预组与安慰剂组总体SF-36评分无显著差异(中位数39.4 vs 43.2,p=0.18),其他健康相关生活质量领域亦无统计学显著差异。

要点

  • 脓毒症休克幸存者中,抗坏血酸+氢化可的松+硫胺素联合治疗未改善90天总体SF-36评分(中位数39.4 vs 43.2,p=0.18)。
  • 该联合方案未在任何其他健康相关生活质量领域显示出统计学显著差异。
  • 仅72例(62%)存活至90天且可联系者完成SF-36,样本量有限。
  • 研究为二次分析,原始试验纳入脓毒症休克患者,干预为静脉抗坏血酸1500 mg、氢化可的松50 mg、硫胺素100 mg每6小时一次共4天。

适用人群与场景

  • 纳入:参加Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis随机对照试验(NCT03389555)的脓毒症休克患者,存活至入组后90天且能通过电话联系。
  • 排除:原文未提及具体排除标准。

诊断标准与关键阈值

  • 脓毒症休克诊断标准:原文未提及。
  • 健康相关生活质量评估:采用Short Form 36问卷(SF-36)。

处置流程与药物剂量

  • 干预组:静脉给予抗坏血酸1500 mg、氢化可的松50 mg和硫胺素100 mg,每6小时一次,共4天。
  • 对照组:安慰剂。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:随机对照试验(NCT03389555)的二次分析。
  • 人群:脓毒症休克存活至90天且可电话联系的患者。
  • 干预与对照:静脉抗坏血酸1500 mg、氢化可的松50 mg、硫胺素100 mg每6小时一次共4天 vs 安慰剂。
  • 主要终点结果:总体SF-36评分中位数干预组39.4(IQR 31.2-45.4)vs 安慰剂组43.2(IQR 37.0-46.7),p=0.18,无显著差异。
  • 关键次要终点:其他健康相关生活质量领域均无统计学显著差异。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:随机对照试验的二次分析。
  • 证据等级或推荐强度:原文未提及。
  • 局限:二次分析;仅62%存活者可联系并完成问卷,样本量小(72例);开放标签?原文未提及;单国多中心。

对床旁实践的改变

  • 对于脓毒症休克患者,不应期望抗坏血酸、氢化可的松和硫胺素联合治疗能改善90天健康相关生活质量。
  • 该结果不改变原始试验对死亡率等主要结局的结论,原文未提及对急性期处置的影响。
  • 适用人群:脓毒症休克存活至90天且可电话随访者;不适用于其他人群。
  • 常见陷阱:不能将生活质量无改善误解为治疗有害;样本量小、失访率高可能影响结果解释。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

UNLABELLED: Patients who experience sepsis often have long-term effects that may impact health-related quality of life. This study aimed to investigate whether the combination of ascorbic acid, corticosteroids, and thiamine compared with placebo improves health-related quality of life in patients with septic shock.

DESIGN: Secondary analysis of the Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis randomized controlled trial (NCT03389555).

SETTING: Thirteen tertiary-care hospitals in the United States.

PATIENTS: Patients who were enrolled in Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis, survived to 90 days post enrollment and were able to be contacted by telephone.

INTERVENTIONS: Patients were randomly assigned to parenteral ascorbic acid (1,500 mg), hydrocortisone (50 mg), and thiamine (100 mg) every 6 hours for 4 days or placebo.

MEASUREMENTS AND MAIN RESULTS: One hundred seventeen patients (59%) survived to 90 days and were administered the Short Form 36 questionnaire; of these, 72 (62%) completed the Short Form 36 (38 [53%] in the intervention group, 34 [47%] in placebo). Sixty-six (92%) completed all survey questions (36 [95%] in the intervention group, 30 [88%] in placebo). There was no significant difference in overall Short Form 36 score between intervention and placebo group (median score: 39.4 [interquartile range, 31.2-45.4] vs 43.2 [37.0-46.7], respectively, p = 0.18). We found no statistically significant difference between the two groups in any of the other health-related quality of life domains used.

CONCLUSIONS: We found no difference in the health-related quality of life in patients with septic shock treated with a combination of ascorbic acid, corticosteroids, and thiamine compared to placebo.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Grossestreuer AV, Moskowitz A, Andersen LW, et al. Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Health-Related Quality of Life in Sepsis. Crit Care Explor. 2020. PMID: 33251516. doi:10.1097/CCE.0000000000000270

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。